We are hiring !

Axonal – Biostatem

Axonal-Biostatem, a leader in clinical research and development, becomes Heva, a subsidiary of Docaposte

Management of clinical trial projects and epidemiological studies in France and international

our purpose

Supporting clinical trials in a more virtuous way

Axonal-Biostatem has been in the TOP 3 of independent French Contract Research Organization (CRO) for more than 10 years, has been present for more than 5 years at European and International level with success. Our purpose is to Participate in the evaluation of treatments and medical devices, thanks to agile teams where collective intelligence is privileged, in order to facilitate patient access to innovative therapies.

Agile and leading CRO

Advise, design, perform and analyze your clinical research
More than a service provide, a partner in your success

AXONAL-BIOSTATEM supports professionals in the pharmaceutical industry, medical devices, biotechnology companies and even academic sponsors on all types of study (Phases I/II to IV, early access studies, non-interventional studies, PASS, SCAC: Post-marketing clinical follow-up, etc.).

We are professionals in the evaluation of health products, we support our clients from the initial reflection stage to the production of publications and reports, in particular those intended for health authorities.

 

AXONAL-BIOSTATEM supports professionals in the pharmaceutical industry, medical devices, biotechnology companies and even academic sponsors on all types of study (Phases I/II to IV, early access studies, non-interventional studies, PASS, SCAC: Post-marketing clinical follow-up, etc.).

We are professionals in the evaluation of health products, we support our clients from the initial reflection stage to the production of publications and reports, in particular those intended for health authorities.

 

Top 3 Contract Research Organization

AXONAL-BIOSTATEM is one of the 3 largest contract research organization in France and is expanding its activity in Europe and around the world (Maghreb, Africa, Brazil, Argentina, Mexico, etc.).

Complete study project management

AXONAL-BIOSTATEM experts are able to provide full or partial clinical study project management based on customer recommendations. They adapt to all types of projects, whether pre-marketing authorization or post-marketing authorization.

The historical positioning of AXONAL-BIOSTATEM on non-interventional studies as well as on “ATU” and “RTU”, makes the company one of the experts in the Early Access and Compassionate Access system set up by the ANSM and the HAS*.

AXONAL-BIOSTATEM is also one of the French leaders in studies linked to the “SNDS”*.

* AXONAL-BIOSTATEM has developed successful partnerships with companies specialized in these 2 subjects.
Clinical studies of medical devices

For more than 15 years, AXONAL-BIOSTATEM has also been managed clinical study projects on medical devices (CE pre-marking or post-marking (SCAC)).

team

Services

For more than 30 years, AXONAL-BIOSTATEM – a leading French CRO recognized as a strategic, reliable and essential partner – has offered global or partial management of your clinical or epidemiological research projects, in France and international. AXONAL-BIOSTATEM supports drug and medical device manufacturers, biotechnology companies and also academic sponsors in the management of clinical trials and studies (Phases I/II to IV), pharmacoepidemiological studies, surveys and observatories.

COMPETENCE, EXPERIENCE AND VERSATILITY

Our areas of expertise

Drugs

  • We design and implement all types of drug studies
  • Clinical studies from phase I to phase IV
  • Non-interventional studies in the form of a register, observatory, cohort study
  • Early and Compassionate Access: Help holders of innovative molecules in the drafting of the protocol for early or compassionate programs, implement all the logistics necessary for the management of data collection, write periodic reports for HAS or the ANSM

Medical devices

  • We design and implement studies or data collection
  • We carry out studies to obtain CE marking, post-marking studies to request reimbursement in France, SCACs to respond to HAS post-registration requests
  • We have all the expertise and jobs in-house to carry out a full study
  • Our internal and external consultants can draft marking and reimbursement files in France

Other health products

We also have the competence to design the methodology and carry out any type of study in health fields such as non-drug interventions, cosmetology, nutrition, homeopathy, veterinary medicine.

Other expertises

  • Design and organization of seminars and training on topics related to our expertise and the analysis of health data
  • Provision of technical solutions (eCRF, ePRO, IWRS randomization, apps on smartphones and tablets, development of specific applications)
  • Advice and assistance in responding to study requests from the authorities
  • Methodological advice in the development of protocols
  • Medical writing: protocol, newsletter, study reports, abstract, poster, scientific article
  • Assistance in finding research funding

Quality management

Client focus

With a Quality Management System that has existed for more than 25 years, our approach is voluntary, structuring and bears confidence and growth.

Our procedures are “living” and follow the evolution of clinical research. A clinical or epidemiological research project is always unique: our objective is the success of this project and customer satisfaction remains the best recognition for the entire company.

recommendations

Opinions of our customers

“It was my first project here at RWD Europe when I joined in 2019 and I was really lucky to work with all of you. Axonal is a very good partner and RWD Europe will definitely recommend you for any future projects."

Project Manager of a big Pharma / Real World Data Generation Europe

News

07/12/2023

Axonal-Biostatem and Docaposte in exclusive negotiations

Docaposte has entered into exclusive negotiations with Axonal-Biostatem for its acquisition. This merger is based on a shared vision: the strategic use of data, a keystone in the transformation of the healthcare system. Our collaboration aims to guarantee medical research stakeholders access to quality data on pathologies, treatments and medical devices. Together, we are helping to promote data reliability and integrity.